ChemicalBook--->CAS DataBase List--->651029-09-3

651029-09-3

651029-09-3 Structure

651029-09-3 Structure
IdentificationBack Directory
[Name]

KCL 440
[CAS]

651029-09-3
[Synonyms]

KCL 440
RS57639
RS-57639
RS 57639
1(2H)-Isoquinolinone, 4-[4-[(dimethylamino)methyl]phenyl]-5-hydroxy-
[Molecular Formula]

C18H18N2O2
[MDL Number]

MFCD19443779
[MOL File]

651029-09-3.mol
[Molecular Weight]

294.35
Chemical PropertiesBack Directory
[Boiling point ]

512.4±50.0 °C(Predicted)
[density ]

1.230±0.06 g/cm3(Predicted)
[pka]

8.29±0.20(Predicted)
Hazard InformationBack Directory
[Uses]

KCL-440 is a CNS-penetrated PARP inhibitor, with an IC50 of 68 nM. KCL-440 has strong inhibition of PARP-1[1][2].
[in vivo]

The brain concentration of KCL-440 is sufficient to inhibit the PARP activity during the intravenous infusion at the rate of 1 mg/kg/h[1].
KCL-440 (over 0.03 mg/kg/h) exhibits neuroprotective effects of KCL-440 in the in vivo cerebral ischemia model[1].

Animal Model:Rat acute cerebral infarction model induced by photothrombotic MCA occlusion[1].
Dosage:0.01, 0.03, 0.1, 0.3, 1.0, and 3.0 mg/kg/h.
Administration:Intravenously administered at a rate of 0.33 ml/kg/h for 24 h immediately after cerebral ischemia.
Result:The serum concentration of KCL-440 approached steadystate levels within 1 h in rats that were intravenously infused at the rate of 1 mg/kg/h for 6 h. One hour after the initiation of infusion, the serum concentration of KCL-440 is 0.11 μg/mL, which is equivalent to 0.37 μM. The brain:serum concentration ratio after a 6-h infusion at 10 mg/kg/h is 0.8.
Led to a dose-dependent reduction in the cerebral infarct size at 24 h after the MCA occlusion.
[References]

[1] Yasuhiko Ikeda, et al. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model. Brain Res. 2005 Oct 26;1060(1-2):73-80. DOI:10.1016/j.brainres.2005.08.046
[2] Tatsushi Kamiya, et al. The neuroprotective effects of a newly synthesized poly (ADP-ribose) polymerase (PARP) inhibitor (KCL-440) on neuronal cell death following transient focal ischemia in rat. Journal of Cerebral Blood Flow & Metabolism. 2005.
651029-09-3 suppliers list
Company Name: TargetMol  
Telephone: 400-821-0310 15002144251
Website: www.targetmol.cn/
Company Name: Hangzhou MolCore BioPharmatech Co.,Ltd.  
Telephone: +86-057181025280; +8617767106207
Website: https://www.molcore.com/
Tags:651029-09-3 Related Product Information
656234-19-4 656234-36-5 656234-38-7 651029-12-8 656234-40-1 59647-24-4